Tetraploidization Increases the Motility and Invasiveness of Cancer Cells
International Journal of Molecular Sciences · 10.09.2023 · 24 (18) · 13926
DOI: 10.3390/ijms241813926 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.09.2023. Verfasst von Mohamed Jemaà und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Translational Cancer Research, Faculty of Medicine, Lund University, 22381 Lund, Sweden. Hauptthemen laut MEDLINE: Tetraploidy, Colonic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenner-Gren Foundation, Per-Eric and Ulla Schyberg’s Foundation, The Royal Physiographic Society of Lund Natural Sciences, Medicine and Technology.
Abstract (Originalsprache)
Polyploidy and metastasis are associated with a low probability of disease-free survival in cancer patients. Polyploid cells are known to facilitate tumorigenesis. However, few data associate polyploidization with metastasis. Here, by generating and using diploid (2n) and tetraploid (4n) clones from malignant fibrous histiocytoma (MFH) and colon carcinoma (RKO), we demonstrate the migration and invasion advantage of tetraploid cells in vitro using several assays, including the wound healing, the OrisTM two-dimensional cell migration, single-cell migration tracking by video microscopy, the Boyden chamber, and the xCELLigence RTCA real-time cell migration. Motility advantage was observed despite tetraploid cell proliferation weakness. We could also demonstrate preferential metastatic potential in vivo for the tetraploid clone using the tail vein injection in mice and tracking metastatic tumors in the lung. Using the Mitelman Database of Chromosome Aberrations in Cancer, we found an accumulation of polyploid karyotypes in metastatic tumors compared to primary ones. This work reveals the clinical relevance of the polyploid subpopulation and the strategic need to highlight polyploidy in preclinical studies as a therapeutic target for metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Translational Cancer Research, Faculty of Medicine, Lund University, 22381 Lund, Sweden.
- Human Genetics Laboratory (LR99ES10), Faculty of Medicine of Tunis (FMT), Tunis El Manar University, Tunis 1006, Tunisia.
- Department of Biology, Faculty of Science of Tunis, Tunis El Manar University, Tunis 2092, Tunisia.
- Department of Pathology, Habib Bourguiba Hospital, Sfax University, Sfax 3029, Tunisia.
- Department of Laboratory Medicine, Division of Clinical Genetics Lund University, 22381 Lund, Sweden.
- Department of Radiation Oncology, University Hospital of Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany.
ORCID-Profile: Mohamed Jemaà, Renee Daams, Slim Charfi, Ramin Massoumi
Förderung
- Wenner-Gren Foundation
- Per-Eric and Ulla Schyberg’s Foundation
- The Royal Physiographic Society of Lund Natural Sciences, Medicine and Technology
- Gunnar Nilssons Cancerstiftelse
- Swedish Cancer Foundation
Zitieren
APA
Jemaà, M., Daams, R., Charfi, S., Mertens, F., Huber, S. M., & Massoumi, R. (2023). Tetraploidization Increases the Motility and Invasiveness of Cancer Cells. International Journal of Molecular Sciences, 24(18), 13926. https://doi.org/10.3390/ijms241813926
Vancouver
Jemaà M, Daams R, Charfi S, Mertens F, Huber SM, Massoumi R. Tetraploidization Increases the Motility and Invasiveness of Cancer Cells. International Journal of Molecular Sciences. 2023;24(18):13926. doi:10.3390/ijms241813926
BibTeX
@article{Jema2023,
author = {Jemaà, Mohamed and Daams, Renee and Charfi, Slim and Mertens, Fredrik and Huber, Stephan M and Massoumi, Ramin},
title = {Tetraploidization Increases the Motility and Invasiveness of Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {18},
pages = {13926},
doi = {10.3390/ijms241813926}
}
EUVIMED